British girl dies after cervical cancer vaccine jab

Sep 29, 2009

British drug giant GlaxoSmithKline said Tuesday it was working with health authorities here probing the death of a schoolgirl following a cervical cancer vaccination.

The 14-year-old died on Monday after an adverse reaction to the Cervarix vaccine at her school in Coventry, central England, as part of a national vaccination to protect women against the disease.

Health authorities have isolated the batch of vaccine used in the school involved against the (HPV), a sexually-transmitted virus which is the primary cause of .

"The incident happened shortly after the girl had received her in the school," said Dr. Caron Grainger, joint head of public health for the National Health Service (NHS) in Coventry and Coventry City Council.

"No link can be made between the death and the vaccine until all the facts are known and a post-mortem takes place."

She added: "We are conducting an urgent and full investigation into the events surrounding this tragedy."

In a statement GSK, which produces Cervarix, said it was working with health authorities "to better understand this case, as at this stage the exact cause of this tragic death is unknown.

"As a precautionary measure, the batch of vaccine involved has been quarantined until the situation is fully understood," it said, noting that over 1.4 million doses of Cervarix have been given in Britain.

And it added: "To date the vast majority of suspected adverse reactions (to Cervarix) have related either to the signs and symptoms of recognised side effects listed in the product information or were due to the injection process and not the vaccine itself."

Awareness of cervical cancer was boosted earlier this year by the death from the disease of a reality television star, Jade Goody, who garnered publicity notably for the need for women to have regular cervical smear tests.

(c) 2009 AFP

Explore further: FDA approves hard-to-abuse narcotic painkiller

add to favorites email to friend print save as pdf

Related Stories

Study on government's controversial choice of HPV vaccine

Jul 18, 2008

The UK government may save up to £18.6 million a year by deciding to use the HPV vaccine Cervarix, given that it is equally effective as the more expensive Gardasil in preventing cervical abnormalities, according to a study ...

WHO approves cervical cancer vaccine Cervarix

Jul 09, 2009

(AP) -- The World Health Organization has approved a second cervical cancer vaccine, this one made by GlaxoSmithKline, meaning U.N. agencies and partners can now officially buy millions of doses of the vaccine for poor countries ...

The HPV vaccine that doctors would recommend

Oct 24, 2008

Despite the government's decision to choose the vaccine Cervarix for the UK human papillomavirus (HPV) vaccination programme, every doctor I have spoken to has chosen Gardisal for their own children, says a doctor on bmj.com ...

Recommended for you

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

Tough-to-abuse formulation of oxycodone approved

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

EU regulator: Morning-after pill OK for all women

Jul 24, 2014

(AP)—A commonly used morning-after pill is suitable for use by heavier women, the European Medicines Agency said Thursday after a review of the evidence sparked by the French manufacturer's declaration that the drugs didn't ...

User comments : 3

Adjust slider to filter visible comments by rank

Display comments: newest first

SincerelyTwo
3 / 5 (4) Sep 29, 2009
All of the adverse reactions, which were listed in the product information as recognized side effects, were due to the injection process and not the vaccine?

I smell some B.S., and I'm not even a conspiracy nut. It's just that there's a very glaring logical problem here.
vika_Tae
1 / 5 (1) Sep 29, 2009
Well, I have never liked this vaccine, because well, how the hades do you vaccinate against cancer? That's what it is claiming it can do. Plus of course, once a woman is certain she's vaccinated against the cancer, she is far less likely to attend the horrible annual smear tests, intended to detect formation in time to do something about it.
brianweymes
3 / 5 (2) Sep 29, 2009
The safety of vaccinations is very well established. There are risks, but they are remote, especially when compared to the diseases they prevent. I don't understand what happened in this particular case, but it's the first death in England. In contrast, a quick search reveals that about 750 women die from cervical cancer in England every year. With these statistics, it's hard to argue against vaccination.

There is no evidence those vaccinated are less likely to get pap smears. Furthermore, those most likely to die from cervical cancer do not get them in the first place, so it's a moot point.